Sudarshan Pharma Industries has received GMP and ISO 9001:2015 certifications for its Hyderabad manufacturing facility. The approvals strengthen the company’s credibility in global API and pharmaceutical intermediates markets.
Author: Aditya Pareek | EQMint
Pharmaceutical company Sudarshan Pharma Industries Limited has announced a major milestone that strengthens its global manufacturing credibility.
According to the company’s stock exchange filing dated 18 February 2026, the Hyderabad manufacturing facility has successfully obtained:
- Good Manufacturing Practice (GMP) Certification
- ISO 9001:2015 Quality Management Certification 1
These certifications mark a significant achievement in Sudarshan Pharma share news, reinforcing its positioning in the API and pharmaceutical intermediates sector.
GMP Certification: A Major Global Benchmark
The company confirmed that its Hyderabad facility received GMP certification from UK Certification & Inspection Limited for:
Manufacturing of API Intermediates & Active Pharmaceutical Ingredients The certificate (Page 2) confirms:
- Facility assessed and compliant with GMP standards
- Certification valid until 11 February 2029
- Surveillance audits scheduled in 2027 and 2028
This Sudarshan Pharma GMP certification demonstrates adherence to international pharmaceutical manufacturing standards.
ISO 9001:2015 Certification Strengthens Quality Systems
In addition to GMP approval, the company also received ISO 9001:2015 certification for its quality management system.
The certificate (Page 3) confirms:
- Compliance with global QMS standards
- Certification valid until 11 February 2029
- Covers manufacturing of API intermediates and APIs
The Sudarshan Pharma ISO certification ensures consistent operational quality and continuous improvement processes.
Why GMP Certification Matters for API Manufacturing
The Sudarshan Pharma API manufacturing certification is a major step because GMP standards are critical for:
- Export approvals
- Regulatory compliance
- International partnerships
- Pharmaceutical supply chains
GMP compliance ensures medicines and ingredients are:
Consistently produced Quality controlled Safe for global markets
This strengthens the company’s ability to serve regulated markets.
Hyderabad Facility in Focus
The certifications apply to the company’s manufacturing unit located at:
IDA Medchal, Hyderabad, Telangana
The Sudarshan Pharma Hyderabad facility plays a central role in the company’s API and intermediates production.
The facility’s certification highlights its readiness to operate at global pharmaceutical standards.
Valid Until 2029: Long-Term Compliance
Both certifications remain valid until 11 February 2029, subject to surveillance audits.
This provides:
- Long-term credibility
- Operational stability
- Export readiness
- Improved market trust
Such long validity enhances confidence in Sudarshan Pharma share news developments.
Strengthening Global Market Position
The company stated that these certifications:
- Reinforce global quality benchmarks
- Highlight robust manufacturing practices
- Support continuous operational improvement
- Strengthen positioning as a compliant manufacturer 1
This is a major milestone in expanding Sudarshan Pharma API manufacturing globally.
Why This Matters for the Pharma Sector
India is a global leader in:
- API manufacturing
- Pharmaceutical exports
- Generic drug production
Certifications like GMP and ISO help companies:
Enter regulated markets Partner with global pharma firms Build export pipelines Enhance brand credibility
The Sudarshan Pharma GMP certification aligns the company with global pharma standards.
Investor Perspective
For investors tracking Sudarshan Pharma share news, this development signals:
- Improved regulatory credibility
- Export market readiness
- Stronger compliance framework
- Enhanced growth potential
Quality certifications often act as long-term business enablers in the pharma industry.
Future Growth Opportunities
The certifications open doors for:
- Contract manufacturing partnerships
- Export market expansion
- Regulatory approvals in new geographies
- Larger pharmaceutical collaborations
The Sudarshan Pharma ISO certification strengthens the company’s long-term growth prospects.
Conclusion
The Sudarshan Pharma GMP certification and ISO certification mark a major milestone in the company’s journey toward global pharmaceutical manufacturing excellence.
With its Hyderabad facility now certified under international standards, the company is better positioned to expand in regulated markets and strengthen its presence in the global API supply chain.
This development represents a strong step forward in Sudarshan Pharma API manufacturing growth and long-term credibility.
For more such information visit EQMint
Source link:BSE
Disclaimer: This article is not an investment advice and is for educational purpose only
